NeurologyAntibody TestingCell-Based Assays
Evaluating Antibody Detection Methods in Myasthenia Gravis: Insights from the ADAM Study
By MedXY|Aug 13, 2026
The ADAM Study demonstrates superior diagnostic accuracy of live cell-based assays over fixed cell-based and ELISA tests for detecting AChR antibodies in myasthenia gravis, highlighting important clinical implications for antibody testing s
